Edward C. Saltzman's most recent trade in Nurix Therapeutics Inc was a trade of 31,250 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Edward C. Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 31,250 | 31,250 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Edward C. Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Edward C. Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Edward C. Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Edward C. Saltzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 50,000 | 50,000 | - | - | Director Stock Option (right to buy) |